Maumee, OHNCT06605404Now EnrollingIRB Ready

Muscle Invasive Bladder Urothelial Carcinoma Clinical Trial in Maumee, OH

Access cutting-edge muscle invasive bladder urothelial carcinoma treatment through this clinical trial at a research site in Maumee. Study-provided care at no cost to qualified participants.

Sponsored by Paradigm Health

Quick Self-Assessment

See if you qualify for this Maumee location

Preparing your pre-screening questions…

Expert Care in Maumee

Access muscle invasive bladder urothelial carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related muscle invasive bladder urothelial carcinoma treatment provided free

Apply for This Maumee Location

Check if you qualify for this muscle invasive bladder urothelial carcinoma clinical trial in Maumee, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Maumee

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Maumee site if eligible
  4. 4Begin participation

About This Muscle Invasive Bladder Urothelial Carcinoma Study in Maumee

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.

Sponsor: Paradigm Health

Who Can Participate

Inclusion Criteria

Eligibility Criteria:
Age 18 years or older.
Confirmed histological or cytological diagnosis of a malignant solid tumor that is either specified in one of the pre-defined tumor cohorts or meets the enrollment criteria for the Mix of Solid Tumors (MOST) cohort (Table 1).
Eligible for curative intent therapy, with surgical resection of cancer planned. a. If surgical resection has occurred, enrollment should occur within 3 months of surgical resection and before initiation of adjuvant therapy.
Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2.
No systemic therapy for current cancer diagnosis administered before enrollment.
Willing and able to comply with required study procedures, including blood sample collection and primary tumor tissue submission from diagnostic biopsy or surgical excision.
Has completed all therapy (including endocrine therapy) 3 or more years ago for any previous invasive solid organ malignancy (with exception of nonmelanoma skin cancers) or hematologic malignancy. Individuals with a prior history of noninvasive (in situ) carcinomas may participate if they have received definitive treatment (no washout period required).
No concurrent diagnosis of another invasive cancer, except for nonmelanoma skin cancers.
No prior allogeneic hematopoietic stem cell transplant.
Able and willing to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information. Cohort Specific Criteria
Muscle-invasive urothelial carcinoma of the bladder and Melanoma Cohorts: Stage II or operable III cancer:
Esophageal, Gastric/GEJ, and NSCLC Cohorts: Stage I, II, or operable III cancer.
Pancreatic Cohort: Stage I, II or operable III cancer, exocrine only disease.
MOST cohort: Stage II or operable stage III solid tumor diagnosis that meets eligibility criteria and is not included in the other cohorts. The following tumor types are excluded:
Central nervous system (CNS) malignancies
Colorectal cancer
Breast cancer
Squamous cell skin cancer
Basal cell carcinoma
Gastrointestinal stromal tumors (GIST)
Thyroid cancer
Uveal melanoma
Low or intermediate grade neuroendocrine tumors ■ Eligible tumor types: High-grade neuroendocrine tumors, including neuroendocrine carcinomas, Merkel cell carcinomas, and small cell lung cancer are permissible
Hematologic cancers including multiple myeloma or other plasma cell dyscrasias, Hodgkin\'s lymphoma, non-Hodgkin\'s lymphoma, acute or chronic leukemias including chronic lymphocytic leukemia / small lymphocytic leukemia

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Maumee?

Yes, this clinical trial (NCT06605404) has an active research site in Maumee, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Muscle Invasive Bladder Urothelial Carcinoma Treatment Options in Maumee, OH

If you're searching for muscle invasive bladder urothelial carcinoma treatment options in Maumee, OH, this clinical trial (NCT06605404) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Maumee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced muscle invasive bladder urothelial carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all muscle invasive bladder urothelial carcinoma clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Maumee, OH

See all bladder cancer clinical trials recruiting in Maumee — not just this study.

Browse Bladder Cancer Trials in Maumee →

Browse More Trials by Condition

Bladder Cancer TrialsAlzheimers Disease TrialsADHD TrialsAnkylosing Spondylitis TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Maumee?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Maumee, OH